You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid tumor Malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Refractory Cancer Trial (GV20-0251)

Not yet recruiting
  • Solid Tumor, Adult
  • Refractory Cancer
  • (no location specified)
Dec 21, 2022

Oligoprogressive Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

Not yet recruiting
  • Oligoprogressive
  • (no location specified)
May 5, 2023

Advanced Pancreatic Cancer, Solid Tumor Malignancies Trial run by the (ProAgio)

Recruiting
  • Advanced Pancreatic Cancer
  • Solid Tumor Malignancies
  • Bethesda, Maryland
    National Cancer Institute
Sep 26, 2022

Advanced Or Metastatic Solid Tumor Malignancies Trial (SHR-A2102)

Not yet recruiting
  • Advanced Or Metastatic Solid Tumor Malignancies
  • (no location specified)
Feb 9, 2023

Metastatic Solid Tumor, Advanced Solid Tumor Trial (XT-0528)

Not yet recruiting
  • Metastatic Solid Tumor
  • Advanced Solid Tumor
  • (no location specified)
Jul 22, 2022

NSCLC, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Duarte (JANX008)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 29, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Breast Cancer, Colorectal Cancer, Uveal Melanoma Trial in Orlando, Pittsburgh (TBio-4101, Pembrolizumab)

Recruiting
  • Breast Cancer
  • +2 more
  • Orlando, Florida
  • +1 more
Feb 1, 2023

Malignant Solid Tumor Trial in Hackensack, New York, Spokane (ZL-1218, Pembrolizumab)

Recruiting
  • Malignant Solid Tumor
  • Hackensack, New Jersey
  • +2 more
May 4, 2023

Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Kansas City, Kansas
  • +2 more
Mar 16, 2023

Cancer Trial in United States (JTX-4014)

Active, not recruiting
  • Cancer
  • Denver, Colorado
  • +3 more
Sep 9, 2022

Solid Tumor, Metastatic Solid Tumor, Solid Carcinoma Trial in New York, Seattle (AZD1390, Stereotactic Body Radiotherapy)

Not yet recruiting
  • Solid Tumor
  • +5 more
  • AZD1390
  • Stereotactic Body Radiotherapy
  • New York, New York
  • +1 more
Jan 12, 2023

Solid Tumor Trial in United States (CI-8993)

Recruiting
  • Solid Tumor
  • Lebanon, New Hampshire
  • +4 more
Jul 19, 2022

Advanced or Metastatic Solid Tumor Malignancies Trial in United States (NP-G2-044 Monotherapy, Anti-PD-(L)1 Therapy, NP-G2-044

Recruiting
  • Advanced or Metastatic Solid Tumor Malignancies
  • NP-G2-044 Monotherapy
  • +2 more
  • Scottsdale, Arizona
  • +14 more
Jan 5, 2023

Coil Arrays in Patients With Advanced Solid Tumor Malignancies

Completed
  • Neoplams
  • MRI
  • San Francisco, California
    University of California, San Francisco
Mar 7, 2022

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Solid Tumor Malignancies Trial in Houston (Autologous lymphocyte infusion (ALI))

Recruiting
  • Solid Tumor Malignancies
  • Autologous lymphocyte infusion (ALI)
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Trial in Chuo-ku (ASP1948)

Completed
  • Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
  • Chuo-ku, Tokyo, Japan
    Site JP810001
Jan 17, 2023

Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer, Non Small Cell Lung Cancer Trial in Baltimore (AG-01 Compound)

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • AG-01 Compound
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
Nov 16, 2022

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

Completed
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 25, 2022

Solid Tumor, Adult Trial in United States (eFT226, Sotorasib, Fulvestrant)

Recruiting
  • Solid Tumor, Adult
  • Los Angeles, California
  • +11 more
Nov 15, 2022

Advanced EGFR Positive Solid Tumor Trial in China, United States (ZZ06)

Recruiting
  • Advanced EGFR Positive Solid Tumor
  • ZZ06
  • Los Angeles, California
  • +3 more
Mar 7, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • TransCon IL-2 β/γ
  • +4 more
  • Boston, Massachusetts
  • +7 more
Nov 16, 2022